These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28588757)
1. Identification of neuron selective androgen receptor inhibitors. Otto-Duessel M; Tew BY; Vonderfecht S; Moore R; Jones JO World J Biol Chem; 2017 May; 8(2):138-150. PubMed ID: 28588757 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction. Beitel LK; Alvarado C; Mokhtar S; Paliouras M; Trifiro M Front Neurol; 2013; 4():53. PubMed ID: 23720649 [TBL] [Abstract][Full Text] [Related]
3. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330 [TBL] [Abstract][Full Text] [Related]
4. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy]. Matsuura T Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845 [TBL] [Abstract][Full Text] [Related]
5. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. Breza M; Koutsis G J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy. Baniahmad A J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449 [TBL] [Abstract][Full Text] [Related]
8. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy. Pennuto M; Gozes I J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173 [TBL] [Abstract][Full Text] [Related]
9. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697 [TBL] [Abstract][Full Text] [Related]
10. Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy. Ramzan F; McPhail M; Rao P; Mo K; Halievski K; Swift-Gallant A; Mendoza-Viveros L; Cheng HY; Monks DA J Neurosci; 2015 Apr; 35(16):6444-51. PubMed ID: 25904795 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355 [TBL] [Abstract][Full Text] [Related]
12. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656 [TBL] [Abstract][Full Text] [Related]
14. In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer. Chen Y; Ruben EA; Rajadas J; Teng NNH Bioorg Med Chem; 2015 Aug; 23(15):4576-4582. PubMed ID: 26164623 [TBL] [Abstract][Full Text] [Related]
15. Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA. Jiménez Garduño AM; Juárez-Hernández LJ; Polanco MJ; Tosatto L; Michelatti D; Arosio D; Basso M; Pennuto M; Musio C Biophys Chem; 2017 Oct; 229():68-76. PubMed ID: 28511915 [TBL] [Abstract][Full Text] [Related]
16. [Molecular pathogenesis of motor neuron diseases]. Sobue G Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045 [TBL] [Abstract][Full Text] [Related]
18. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. Ellerby LM; Hackam AS; Propp SS; Ellerby HM; Rabizadeh S; Cashman NR; Trifiro MA; Pinsky L; Wellington CL; Salvesen GS; Hayden MR; Bredesen DE J Neurochem; 1999 Jan; 72(1):185-95. PubMed ID: 9886069 [TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA). Katsuno M; Adachi H; Inukai A; Sobue G Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186 [TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and AR gene mutations in Kennedy's disease. Liu X; Zhu M; Li X; Tang J Funct Integr Genomics; 2019 May; 19(3):533-539. PubMed ID: 30612224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]